Last updated on July 2019

Long-term Safety Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS


Brief description of study

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study.

Clinical Study Identifier: NCT03650114

Find a site near you

Start Over

Novartis Investigative Site

Cullman, AL United States
  Connect »

Novartis Investigative Site

Fullerton, CA United States
  Connect »

Novartis Investigative Site

Boulder, CO United States
  Connect »

Novartis Investigative Site

Colorado Springs, CO United States
  Connect »

Novartis Investigative Site

Fort Collins, CO United States
  Connect »

Novartis Investigative Site

Atlantis, FL United States
  Connect »

Novartis Investigative Site

Bradenton, FL United States
  Connect »

Novartis Investigative Site

Delray Beach, FL United States
  Connect »

Novartis Investigative Site

Oldsmar, FL United States
  Connect »

Novartis Investigative Site

Ormond Beach, FL United States
  Connect »

Novartis Investigative Site

Pompano Beach, FL United States
  Connect »

Novartis Investigative Site

Port Charlotte, FL United States
  Connect »

Novartis Investigative Site

Sarasota, FL United States
  Connect »

Novartis Investigative Site

West Palm Beach, FL United States
  Connect »

Novartis Investigative Site

Savannah, GA United States
  Connect »

Novartis Investigative Site

Suwanee, GA United States
  Connect »

Novartis Investigative Site

Honolulu, HI United States
  Connect »

Novartis Investigative Site

Northbrook, IL United States
  Connect »

Novartis Investigative Site

Indianapolis, IN United States
  Connect »

Novartis Investigative Site

Alexandria, LA United States
  Connect »

Novartis Investigative Site

Baton Rouge, LA United States
  Connect »

Novartis Investigative Site

Wellesley, MA United States
  Connect »

Novartis Investigative Site

Detroit, MI United States
  Connect »

Novartis Investigative Site

Golden Valley, MN United States
  Connect »

Novartis Investigative Site

Chesterfield, MO United States
  Connect »

Novartis Investigative Site

Saint Louis, MO United States
  Connect »

Novartis Investigative Site

Great Falls, MT United States
  Connect »

Novartis Investigative Site

Asheville, NC United States
  Connect »

Novartis Investigative Site

Greensboro, NC United States
  Connect »

Novartis Investigative Site

Raleigh, NC United States
  Connect »

Novartis Investigative Site

Winston-Salem, NC United States
  Connect »

Novartis Investigative Site

Cleveland, OH United States
  Connect »

Novartis Investigative Site

Columbus, OH United States
  Connect »

Novartis Investigative Site

Westerville, OH United States
  Connect »

Novartis Investigative Site

Oklahoma City, OK United States
  Connect »

Novartis Investigative Site

Portland, OR United States
  Connect »

Novartis Investigative Site

Willow Grove, PA United States
  Connect »

Novartis Investigative Site

Spartanburg, SC United States
  Connect »

Novartis Investigative Site

Johnson City, TN United States
  Connect »

Novartis Investigative Site

Knoxville, TN United States
  Connect »

Novartis Investigative Site

El Paso, TX United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

Lubbock, TX United States
  Connect »

Novartis Investigative Site

Round Rock, TX United States
  Connect »

Novartis Investigative Site

San Antonio, TX United States
  Connect »

Novartis Investigative Site

Sherman, TX United States
  Connect »

Novartis Investigative Site

Salt Lake City, UT United States
  Connect »

Novartis Investigative Site

Virginia Beach, VA United States
  Connect »

Novartis Investigative Site

Kirkland, WA United States
  Connect »

Novartis Investigative Site

Green Bay, WI United States
  Connect »

Novartis Investigative Site

Neuburg an der Donau, Germany
  Connect »

Novartis Investigative Site

Sittard-Geleen, Netherlands
  Connect »

Novartis Investigative Site

Ekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Kazan, Russian Federation
  Connect »

Novartis Investigative Site

Krasnoyarsk, Russian Federation
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Novosibirsk, Russian Federation
  Connect »

Novartis Investigative Site

Pozuelo de Alarcon, Spain
  Connect »

Novartis Investigative Site

Castilleja de la cuesta, Spain
  Connect »

Novartis Investigative Site

Maitland, FL United States
  Connect »

Novartis Investigative Site

Overland Park, KS United States
  Connect »

Novartis Investigative Site

New Lambton Heights, Australia
  Connect »

Novartis Investigative Site

Kemerovo, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

L Hospitalet De Llobregat, Spain
  Connect »

Novartis Investigative Site

Las Vegas, NV United States
  Connect »

Novartis Investigative Site

Charlotte, NC United States
  Connect »

Novartis Investigative Site

Greenfield Park, QC Canada
  Connect »

Novartis Investigative Site

Nizhny Novgorod, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Banska Bystrica, Slovakia
  Connect »

Novartis Investigative Site

Sacramento, CA United States
  Connect »

Novartis Investigative Site

Pensacola, FL United States
  Connect »

Novartis Investigative Site

Kansas City, KS United States
  Connect »

Novartis Investigative Site

Cordova, TN United States
  Connect »

Novartis Investigative Site

Milwaukee, WI United States
  Connect »

Novartis Investigative Site

Santa Maria da Feira, Portugal
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Tyumen, Russian Federation
  Connect »

Novartis Investigative Site

Haseki / Istanbul, Turkey
  Connect »